See more : Babcock & Wilcox Enterprises, I (BWNB) Income Statement Analysis – Financial Results
Complete financial analysis of Landec Corporation (LNDC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Landec Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Texas Mineral Resources Corp. (TMRC) Income Statement Analysis – Financial Results
- Harvest Gold Corporation (HVG.V) Income Statement Analysis – Financial Results
- Orbia Advance Corporation, S.A.B. de C.V. (ORBIA.MX) Income Statement Analysis – Financial Results
- Mana Capital Acquisition Corp. (MAAQU) Income Statement Analysis – Financial Results
- Montea Comm. VA (MONT.BR) Income Statement Analysis – Financial Results
Landec Corporation (LNDC)
About Landec Corporation
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 185.79M | 544.16M | 590.37M | 557.56M | 524.23M | 532.26M | 541.10M | 539.26M | 476.81M | 441.71M | 317.55M | 276.73M | 238.22M | 235.94M | 238.53M | 210.50M | 231.95M | 205.23M | 192.09M | 0.00 | 190.88M | 209.55M | 35.40M | 33.50M | 9.50M | 2.50M |
Cost of Revenue | 135.42M | 462.69M | 515.38M | 476.56M | 445.89M | 449.07M | 470.14M | 473.85M | 414.25M | 378.95M | 265.41M | 230.03M | 204.46M | 201.66M | 200.30M | 178.11M | 191.91M | 173.26M | 162.30M | 0.00 | 163.30M | 170.12M | 19.30M | 18.20M | 5.10M | 500.00K |
Gross Profit | 50.37M | 81.47M | 74.99M | 81.00M | 78.34M | 83.19M | 70.96M | 65.41M | 62.56M | 62.76M | 52.14M | 46.70M | 33.77M | 34.28M | 38.23M | 32.39M | 40.04M | 31.97M | 29.79M | 0.00 | 27.59M | 39.43M | 16.10M | 15.30M | 4.40M | 2.00M |
Gross Profit Ratio | 27.11% | 14.97% | 12.70% | 14.53% | 14.94% | 15.63% | 13.11% | 12.13% | 13.12% | 14.21% | 16.42% | 16.87% | 14.17% | 14.53% | 16.03% | 15.39% | 17.26% | 15.58% | 15.51% | 0.00% | 14.45% | 18.82% | 45.48% | 45.67% | 46.32% | 80.00% |
Research & Development | 7.84M | 10.22M | 11.10M | 11.47M | 12.80M | 9.47M | 7.23M | 6.99M | 7.20M | 9.29M | 9.63M | 9.28M | 4.36M | 3.67M | 3.25M | 3.07M | 3.04M | 2.54M | 3.73M | 0.00 | 3.27M | 4.70M | 5.80M | 5.70M | 7.60M | 3.80M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 46.13M | 65.36M | 72.19M | 64.06M | 51.95M | 55.63M | 49.52M | 39.96M | 35.17M | 32.53M | 26.52M | 24.61M | 17.70M | 18.02M | 19.80M | 21.62M | 27.98M | 23.41M | 22.00M | 0.00 | 26.97M | 28.88M | 11.20M | 10.80M | 4.70M | 3.30M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.93M | 1.42M | 4.78M | 0.00 | 0.00 | 0.00 | -22.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.07M | 2.20M | 2.10M | 1.10M | 500.00K |
Operating Expenses | 53.97M | 75.59M | 83.29M | 75.53M | 64.75M | 65.10M | 56.74M | 46.95M | 42.37M | 37.89M | 37.56M | 38.66M | 22.06M | 21.68M | 23.05M | 2.02M | 31.02M | 25.96M | 25.74M | 0.00 | 30.24M | 39.64M | 19.20M | 18.60M | 13.40M | 7.60M |
Cost & Expenses | 189.38M | 538.27M | 598.67M | 552.08M | 510.64M | 514.17M | 526.89M | 520.80M | 456.62M | 416.84M | 302.98M | 268.70M | 226.52M | 223.34M | 223.35M | 180.13M | 222.93M | 199.21M | 188.04M | 0.00 | 193.53M | 209.76M | 38.50M | 36.80M | 18.50M | 8.10M |
Interest Income | 81.00K | 48.00K | 103.00K | 145.00K | 211.00K | 16.00K | 71.00K | 315.00K | 260.00K | 179.00K | 180.00K | 430.00K | 834.00K | 1.31M | 2.22M | 1.95M | 633.00K | 214.00K | 247.00K | 0.00 | 617.00K | 617.00K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 17.36M | 15.34M | 9.60M | 5.23M | 1.95M | 1.83M | 1.99M | 1.83M | 1.65M | 2.01M | 929.00K | 820.00K | 88.00K | 8.00K | -22.00K | -251.00K | -452.00K | -414.00K | -1.55M | 0.00 | -2.79M | -2.79M | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 17.88M | 19.87M | 18.84M | 15.23M | 12.41M | 10.68M | 9.40M | 7.09M | 7.11M | 7.30M | 5.62M | 5.31M | 3.36M | 3.14M | 3.20M | 3.26M | 3.20M | 3.47M | 3.71M | 0.00 | 5.43M | 6.07M | 2.20M | 2.10M | 1.10M | 500.00K |
EBITDA | -46.28M | -13.50M | -22.87M | 22.39M | 29.83M | 27.43M | -7.66M | 18.46M | 20.19M | 24.87M | 14.58M | 14.23M | 11.70M | 16.49M | 15.18M | 34.91M | 9.02M | 6.02M | 4.06M | 0.00 | -13.36M | 2.03M | -500.00K | -600.00K | -7.50M | -3.70M |
EBITDA Ratio | -36.62% | -0.97% | -3.87% | 4.02% | 5.69% | 5.15% | -1.42% | 5.60% | 8.07% | 9.36% | 8.32% | 5.14% | 4.91% | 6.99% | 8.43% | 16.58% | 5.11% | 4.32% | 3.44% | 0.00% | -7.00% | 0.97% | -1.41% | -1.79% | -78.95% | -148.00% |
Operating Income | -85.91M | -25.12M | -41.70M | 7.16M | 11.85M | 16.28M | -17.06M | 16.95M | 18.80M | 23.04M | 13.83M | 7.64M | 12.45M | 13.35M | 15.18M | 30.37M | 9.02M | 6.02M | 2.90M | 0.00 | -18.79M | -4.04M | -2.70M | -2.70M | -8.60M | -4.20M |
Operating Income Ratio | -46.24% | -4.62% | -7.06% | 1.28% | 2.26% | 3.06% | -3.15% | 3.14% | 3.94% | 5.22% | 4.35% | 2.76% | 5.23% | 5.66% | 6.36% | 14.43% | 3.89% | 2.93% | 1.51% | 0.00% | -9.84% | -1.93% | -7.63% | -8.06% | -90.53% | -168.00% |
Total Other Income/Expenses | -5.84M | -15.34M | -9.60M | -3.52M | 4.55M | -1.26M | -1.79M | 4.52M | 11.13M | 7.40M | 6.46M | 410.00K | -3.73M | -8.00K | 1.72M | 1.28M | -396.00K | -619.00K | 0.00 | 0.00 | 13.95M | 521.00K | 0.00 | 0.00 | 1.70M | 1.50M |
Income Before Tax | -52.12M | -40.47M | -51.31M | 3.64M | 16.40M | 15.01M | -18.85M | 21.47M | 29.93M | 32.26M | 20.28M | 8.44M | 8.73M | 13.34M | 16.90M | 31.65M | 8.63M | 5.40M | 2.93M | 0.00 | -4.84M | -2.13M | -2.70M | -2.70M | -6.90M | -2.70M |
Income Before Tax Ratio | -28.05% | -7.44% | -8.69% | 0.65% | 3.13% | 2.82% | -3.48% | 3.98% | 6.28% | 7.30% | 6.39% | 3.05% | 3.66% | 5.65% | 7.08% | 15.03% | 3.72% | 2.63% | 1.52% | 0.00% | -2.53% | -1.01% | -7.63% | -8.06% | -72.63% | -108.00% |
Income Tax Expense | -5.84M | -7.80M | -13.12M | 1.52M | -9.36M | 4.34M | -7.40M | 7.75M | 10.58M | 9.45M | 7.19M | 4.18M | 4.26M | 5.61M | 3.35M | 2.46M | -24.00K | -4.00K | 29.00K | 0.00 | 3.04M | -42.00K | 100.00K | 200.00K | 1.70M | 1.50M |
Net Income | -46.28M | -32.67M | -38.19M | 2.12M | 25.76M | 10.68M | -11.45M | 13.73M | 19.34M | 22.81M | 13.10M | 4.26M | 4.47M | 7.73M | 13.54M | 29.19M | 8.65M | 5.40M | 2.90M | 0.00 | -18.79M | -2.08M | -2.80M | -2.90M | -8.60M | -4.20M |
Net Income Ratio | -24.91% | -6.00% | -6.47% | 0.38% | 4.91% | 2.01% | -2.12% | 2.55% | 4.06% | 5.16% | 4.12% | 1.54% | 1.87% | 3.28% | 5.68% | 13.87% | 3.73% | 2.63% | 1.51% | 0.00% | -9.84% | -0.99% | -7.91% | -8.66% | -90.53% | -168.00% |
EPS | -1.57 | -1.11 | -1.31 | 0.07 | 0.92 | 0.39 | -0.42 | 0.51 | 0.72 | 0.86 | 0.51 | 0.16 | 0.17 | 0.30 | 0.52 | 1.16 | 0.35 | 0.23 | 0.14 | 0.00 | -1.15 | -0.13 | -0.21 | -0.23 | -0.77 | -0.55 |
EPS Diluted | -1.57 | -1.11 | -1.31 | 0.07 | 0.92 | 0.39 | -0.42 | 0.50 | 0.71 | 0.86 | 0.50 | 0.16 | 0.17 | 0.29 | 0.50 | 1.10 | 0.34 | 0.22 | 0.12 | 0.00 | -1.15 | -0.13 | -0.21 | -0.22 | -0.77 | -0.55 |
Weighted Avg Shares Out | 29.47M | 29.33M | 29.22M | 29.10M | 27.92M | 27.50M | 27.15M | 26.99M | 26.82M | 26.40M | 25.64M | 26.41M | 26.36M | 26.18M | 26.07M | 25.26M | 24.55M | 23.71M | 21.40M | 21.11M | 16.37M | 15.80M | 13.27M | 12.77M | 11.14M | 7.70M |
Weighted Avg Shares Out (Dil) | 29.47M | 29.33M | 29.22M | 29.10M | 27.92M | 27.65M | 27.15M | 27.34M | 27.12M | 26.63M | 26.13M | 26.63M | 26.63M | 26.75M | 26.94M | 26.56M | 25.66M | 24.61M | 23.56M | 22.86M | 16.37M | 15.80M | 13.27M | 13.33M | 11.14M | 7.70M |
New Strong Sell Stocks for March 2nd
ROSEN, A LEADING INVESTOR FIRM, Continues to Investigate Securities Claims Against Landec Corporation – LNDC
The Law Offices of Frank R. Cruz Continues Its Investigation on Behalf of Landec Corporation (LNDC) Investors
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Landec Corporation and Encourages Investors with Losses to Contact the Firm
SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Investigating Landec Corporation’s Directors and Officers for Breach of Fiduciary Duties – LNDC
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Landec Corporation – LNDC
Glancy Prongay & Murray LLP Continues Its Investigation on Behalf of Landec Corporation Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Landec Corporation Limited Investors
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Landec Corporation and Encourages Investors with Losses to Contact the Firm
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Landec Corporation (LNDC) Investors
Source: https://incomestatements.info
Category: Stock Reports